Summit Wealth & Retirement Planning, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Summit Wealth & Retirement Planning, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$548.35 - $738.84 $660,213 - $889,563	-1,204 Reduced 70.0%	516 $305,000
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $47,609 - $55,874	-80 Reduced 4.44%	1,720 $1.2 Million
Q4 2021 Feb 03, 2022	SELL	$543.48 - $670.97 $61,413 - $75,819	-113 Reduced 5.91%	1,800 $1.14 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $362,212 - $429,685	-631 Reduced 24.8%	1,913 $1.16 Million
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $1.2 Million - $1.42 Million	2,544 New	2,544 $1.42 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Summit Wealth & Retirement Planning, Inc., based on Form 13F filings with the SEC.

Stay updated on Summit Wealth & Retirement Planning, Inc. with notifications on news.